Biomedical research generates a vast amount of information that is ultimately stored in scientific publications or in databases. The information in scientific texts is unstructured and thus hard to access, whereas the information in databases, although more accessible, often lacks in contextualization. The integration of information from these two kinds of sources is crucial for managing and extracting knowledge. By structuring and defining the concepts and relationships within a biomedical domain, BioOntologies have taken a key role in this integration. This chapter describes the role of BioOntologies in sharing, integrating and mining biological information, discusses some of the most relevant BioOntologies and illustrates how they are being used by automatic tools to improve our understanding of life.
INTRODUCTION
The development of high-throughput techniques, such as DNA sequencing, microarrays and automated gene-function studies, is turning biology into an information-based science. This is reflected in the ever growing amount of biological data stored in databases and articles in scientific publications.
Biomedical databases contain mostly sequence data and annotations 1 on entities, such as genes and proteins. However, sequence data is growing at a far greater rate than the manual annotation of the entities, mainly due to curated annotations requiring experimental results to back them up. These are mostly recorded in the scientific literature. As a result, the annotation of databases falls upon expert curators, which have the difficult and time-consuming task of continuously tracking the literature.
This has prompted the development of data and text mining approaches for automated annotation, which are now responsible for the vast majority of current annotations 2 .
However, extracting knowledge from the literature is far from trivial, due to the inherent complexity of natural language used in scientific texts, preventing automated annotations from achieving the quality attained by expert curators.
In fact, early automated approaches have produced a significant number of misannotations, which are now being propagated due to extrapolation of new annotations derived from them (Devos and Valencia, 2001) . Given that the vast majority of annotations is derived by extrapolation from previous annotations and most annotation efforts do not distinguish between extrapolated and curated annotations, this problem is even more serious (Valencia 2005) .
One way of improving the knowledge extraction process is by integration of the concepts and context of the field (a.k.a the domain knowledge) into the computational methods for annotation, so that they can achieve the same levels of performance of expert curators (Spasic et al., 2005) . Evidently, this requires the translation of the domain knowledge from natural language into a clear, structured and unequivocal form to enable computational reasoning.
The above reasoning leads to the consideration of creating ontologies, which can be defined as data models for representing concepts and their relationships within a given domain, enabling reasoning about the objects in that domain. In addition to their role as a source of domain knowledge in the annotation process, ontologies can also be used directly for annotation: biomedical databases can contain ontology terms annotating their entities instead of containing natural language annotation statements.
This makes annotations more precise and consistent, and opens the way for computational reasoning over the annotations.
The use of ontologies is also advantageous in other data management activities, such as data integration, data cleansing and data mining (Gardner, 2005) . Data integration greatly benefits from the unified view provided by ontologies. If two or more databases share the same ontology for annotating their entities, exchanging and integrating information among them becomes much more efficient. The use of ontologies is also important as a guide for solving semantic conflicts between discrepant data sources. Given these factors, the growing use of ontologies has been a key factor in data integration, shifting the emphasis from knowledge management to knowledge representation.
Data cleansing also benefits from the use of ontologies in that having a structured and precise meaning for concepts in a domain enhances the identification of inconsistent or erroneous database entries and the process of their correction.
Data mining can profit from both data cleansing and data integration, so it benefits indirectly from the use of ontologies. In addition, it also benefits from the use of ontologies as a source of domain knowledge to guide the discovery process and as a semantic setting for expressing discovered patterns in concise terms. 
BIOONTOLOGIES
Since Ancient Greece, philosophy has dealt with the need to define and structure reality. Aristotle proposed a system to organize the objects of human perception in well-defined Categories, beginning with an explanation of synonyms, homonyms and paronyms. He recognized the importance of having clear unequivocal concepts to identify each object. In the 18 th century, Linnaeus applied these same concepts to the natural world and developed a taxonomy for classification of living things. These early ideas have evolved into the current definition of Ontology in philosophy as a systematic account of Existence, and as such much more complex than Classification.
Although the concept of Ontology has been in use by philosophy for a long time, it was only with the emergence of Artificial Intelligence that computer science borrowed the term to establish content-specific agreements for the sharing and reuse of knowledge among software systems. In this context, Gruber defines an ontology as a specification of conceptualisations, used to help programs and humans share knowledge. Conceptualisations refer to the entities: the terms, the relationships between them, and also the constraints of those relationships (Gruber, 1991) . On the other hand, specification refers to the explicit representation of the conceptualisations.
Using this general description, controlled vocabularies, taxonomies and thesaurus can be considered ontologies (Bodenreider and Stevens, 2006 A well structured ontology will reuse ontologies of the three types, but in a clearlydefined modular way to allow structural modification and concept reusability.
The role of BioOntologies has changed in recent years: from limited in scope and scarcely used by the community, to a main focus of interest and investment. Although clinical terminologies have been in use for several decades, different terminologies were used for several purposes, hampering the sharing of knowledge and its reliability. This has lead to the creation of BioOntologies to answer the need to merge and organize the knowledge, and overcome the semantic heterogeneities observed in this domain. While the first attempts at developing them focused on a global schema for resource integration, real success and acceptance was only achieved later by ontologies for annotating bioentities (Bodenreider and Stevens, 2006) . Since then, BioOntologies have been used successfully for other goals, such as description of experimental protocols and medical procedures. The examples that follow represent some of the most widely-used BioOntologies for some of these goals, and also recent efforts for integrated development of BioOntologies.
Gene Ontology
The Gene Ontology 3 (GO) was created for functional annotation of gene products 4 in a cellular context (Ashburner et al, 2000) . It is divided in three aspects (or GO types): molecular function, biological process and cellular component; which constitute three orthogonal ontologies.
Each of these ontologies is structured as a Directed Acyclic Graph (DAG), which is identical to a tree with the exception that terms can have multiple parents (see Figure   1 ). The terms are linked to each other by two types of relationships: is a and part of, the former expressing a simple class-subclass relationship and the latter expressing a part-whole relationship with the particularity that the existence of the whole does not imply the existence of the part. Each DAG has a root term homonymous to the corresponding GO type, and all three are linked to the global root term all.
GO aims at being species-independent. However, as some functional aspects are not common to all life forms, some terms apply only to a given taxonomical group. In such cases, the terms in question specify the taxonomical group to which they apply preceded by the word sensu, as in the term chromosome organization and biogenesis (sensu Eukaryota). and cellular component) and some of their descendent terms. The fact that GO is a DAG rather than a tree is illustrated by the term transcription factor activity which has two parents. An example of a part of relationship is also shown between the terms cell part and cell.
GO was developed by the GO Consortium, initially a collaboration between three model organism databases (FlyBase, SGD and MGD) to address the need for a common and consistent vocabulary to annotate gene products from different organisms. Since its origin, the GO Consortium has grown to 15 members, which cooperate in maintaining and updating the ontology. GO itself has become widely accepted by most gene and protein databases (both general and species specific) as the main vocabulary for annotation.
One measure of GO's success is that it not only has been extensively adopted by the community for its designed purpose, but has also been used for other purposes beyond it, such as functional comparison and function prediction of gene products.
The success of GO is due to two key factors. First, GO had a clear and practical goal, and a limited but useful scope. This helped in keeping it focused throughout its development and, above all, ensured its simplicity and usefulness. Second, GO is developed with the involvement of the community, openly addressing its needs. This contributes to make it accessible for the community it wishes to serve, and ensures that it is kept updated.
Despite this success, there is still room for improvement. Some authors suggest that a different model for representing the concepts may be required to deal with the growing compositionality of GO term names, while others have found dependence relationships between terms which are not accounted for or not possible 5 in the GO structure.
Having been the first ontology of its kind, GO's success has lead to a blossoming of the field of BioOntologies. The relative simplicity of GO is what makes it both useful and accessible to the community. Profound changes to GO should be considered with care, since having a perfect ontology is useless if its complexity is beyond the grasp of most of its user community.
Sequence Ontology
The Sequence Ontology 6 (SO) was developed for annotating biological sequences in a genetic context (Eilbeck et al, 2005) . It encompasses one main aspect, sequence feature, plus three others: sequence attribute, consequences of mutation and chromosome variation; these aspects describe properties of the main aspect at several levels. Like in GO, these three aspects constitute separate ontologies with a DAG structure, with terms linked by is a and part of relationships (see Figure 2 ). However, sequence features can also be linked to sequence attributes with the has quality relationship, and sequence features can be linked non-hierarchically with the adjacent to or member of relationship. Also, as GO, SO is mostly species-independent, although some terms can be limited to certain taxonomic groups (e.g. intron-related terms only occur in Eukaryota).
A subset of SO consisting only of sequence features is available under the name SOFA 7 , which can be used for automated sequence annotation whereas the full SO is intended to be used only by curated genome annotation projects. attribute, and some of their descendent terms. The has quality relationship that links these two aspects is illustrated with the term engineered region which has the quality engineered.
7 Sequence Ontology Feature Annotation SO was also developed by the GO consortium with the goal of unifying the vocabulary used to describe sequence features, facilitating information exchange and retrieval and enabling computational reasoning over sequence annotations. It is a natural complement to GO, with the two together accounting for a large portion of the biological aspects for which there is a need for annotations in a large scale.
However, when SO was developed, the main sequence databases (GenBank, EMBL and DDBJ) already had a well established terminology for sequence annotation (the Feature Table) . This hampers SO's acceptance by the community. The main argument in favour of SO is that it provides an underlying structure for the annotations, whereas the Feature Table is a controlled vocabulary with no formalized structure. The underlying structure of SO greatly facilitates the use of computational tools for mining sequence data, and may lead to its increasing adoption.
MGED Ontology
The Microarray Gene Expression Data (MGED) 8 Ontology (MO) was created for describing microarray experiments, encompassing all aspects from the methodology and experimental design to biological samples (Christian et al, 2003) . MGED is divided in two parts, a core ontology (MCO) and an extended ontology, the former providing a stable basic structure to ensure continuous compatibility with software applications and the latter an extension that enables content evolution (see Figure 3 ).
MO has a simple structure consisting of several orthogonal trees corresponding to its various aspects, mostly linked by is a relationships that are relatively short in length (i.e. the number of levels between the root node and the leaf nodes is small MO was developed by the MGED Society with the goal of providing the required semantics to support the existing MAGE-OM 9 data model, which already provided a standardized format for representing and exchanging microarray experiment data. In addition, it was designed to serve as a resource for the development of computational tools for mining microarray data.
MicroArray Gene Expression Object Model
Besides its wide use for describing microarrays, MO is also being used to describe other types of functional genomics experiments such as proteomics experiments.
Being the first ontology describing a biological experiment, MO has paved the way for other related efforts, which lead to the creation of the integrative Ontology for Biomedical Investigations project (formerly FuGO 10 ).
Unified Medical Language System
The Unified Medical Language System 11 (UMLS) is a compendium (or an integrated ontology) of text mining-oriented biomedical terminology encompassing all aspects of medicine (Bodenreider, 2004 The SPECIALIST Lexicon is an English language lexicon focused on biomedical vocabulary, but also including common English words. Each entry in the lexicon, or lexical item, includes syntactic, morphological and orthographic information, essential for natural language processing (NLP). This lexicon was developed to support an NLP system, also called SPECIALIST, which is available with the UMLS as a set of lexical tools.
The UMLS was developed and is maintained by the US National Library of Medicine, with its main goal being the improvement of accessibility to biomedical information by facilitating its interpretation by computer systems. It successfully addresses the problem of coping with the multiplicity of vocabularies and terminologies in use in medicine through an integrative approach (the Metathesaurus) and complements it with a semantic structure that facilitates computer reasoning (the Semantic Network) and lexical information. This enables NLP-based text mining tools to explore the biomedical literature (the SPECIALIST Lexicon). These three factors, together with the all-encompassing scope of UMLS, make it an invaluable tool for mining medical data in any of its aspects.
Open Biomedical Ontologies
The Open Biomedical Ontologies 12 (OBO) Foundry is a project dedicated to coordinating the development of new BioOntologies (Smith et al, 2007) . It was established to deal with the growing number of efforts in the field that followed after the success of the Gene Ontology.
The OBO Foundry defines a set of principles to which new ontologies should adhere in order to be accepted as members of the project. These are set to ensure high quality and formal rigor, and also interoperability between OBO member ontologies. As of December 2007, the key principles enforced are:
 Open access: the OBO is intended to be a shared community resource, with all member ontologies openly available.  Shared syntax: OBO ontologies must be expressed or expressible in a common shared syntax, which can be either the OBO syntax developed by the project, or OWL, the web ontology language defined by the W3C.
The result of complying with these principles is that OBO ontologies have similar structural aspects and a shared syntax, which facilitates the integration of their information and makes the use of common software tools possible. Furthermore, by ensuring that the ontologies are orthogonal, redundancy is minimized and the problem of having concurrent definitions for the same concepts is avoided.
In this manner, the OBO Foundry project aims at preventing the problem that UMLS was designed to solve. By ensuring that new BioOntologies grow in concert with each other, no a posteriori integrative solution should be required.
TOWARDS AUTOMATIC ANNOTATION
One of the main applications of text mining and data mining in biomedical research is the automatic annotation of biological entities.
The main source of annotation data is the scientific literature, since text is still the preferred medium of communication among biomedical researchers. The main link between text and BioOntologies is a terminology where textual terms are associated to concepts in the BioOntology (Spasic et al., 2005) . However, two main issues arise when linking textual terms to ontologies: the imprecise and inconsistent use of terminology in text and the incompleteness of ontologies. There is a high degree of term ambiguity and variation in the biomedical field, often preventing a direct mapping between ontology concepts and terms in text. Term variation arises from the many synonyms that exist for gene products, diseases, etc, whereas term ambiguity originates from the various sub-domains and niches inherent to the field, where terms can have different meanings depending on the context.
Text Mining (TM) can be used to extract relevant information from the scientific literature to aid in bioentity annotation. The most widespread use of TM in biomedical applications is on the retrieval of small chunks of relevant information from large collections of unstructured text . Typically, TM makes use of:
Information Retrieval (IR), for retrieving and filtering of relevant texts; Information Extraction (IE), to select specific information about predefined entities; Natural Language Processing (NLP), to process natural language into a machine-readable form; and Machine Learning (ML), to classify, cluster and extract relations. All these approaches can benefit from the use of BioOntologies to assist in the semantic interpretation and integration of text.
IR tools are frequently used by the biomedical community (e.g. PubMed). However, it is important to take into consideration synonyms and polysemes, and not restrict IR to exact term matching, in order to achieve a balance between loss of information and loss of relevance. BioOntologies provide not only a semantic layer to define such cases, but also a hierarchical organization which allows expanded querying (e.g.
retrieving documents that do not have the query term but one of its descendents or ancestors).
Biomedical IE can range from simple Named Entity Recognition (NER) to the more complex extraction of relations, networks, etc. NER is the identification and mapping of a term detected in text to a concept; since many term occurrences are variants, it is possible to use the list of terms present in a BioOntology to derive a training set to detect new terms. To extract more complex types of information, BioOntologies should be used beyond their lexical properties, guiding and constraining the semantic analysis with their structural and relational properties.
The application of NLP to BioLiterature can profit from the integrated use of BioOntologies at different levels: tokenization (e.g.: recognizing "androgen receptor"
as an entity, rather than two separate ones), syntactic processing (parsing the syntactic structure often implies the semantic relations between the concepts), sense disambiguation (referring to the definition of a term in a BioOntology can elucidate the correct meaning of the term in the text). In addition, the simultaneous use of NLP and BioOntologies allows higher quality inferences to be made, by translating the linguistic structures generated by NLP into an ontology-based schema with its finergrained representation of knowledge (Friedman et al., 2006) .
BioOntologies can be used as training corpora for ML techniques, either as simple lists of classified terms, or making use of the relational and hierarchical information to perform clustering and classification.
Biomedicine is an inherently complex area and, as such, coherent and concise annotations of bioentities are crucial for computational reasoning. Traditional TM techniques have been shown to fall short of the biomedical community's needs, performing worse than in other domains. To be successful, TM applications need to be supported by an explicit semantic representation of the kind provided by ontologies. Below, we describe four tools than can be used to retrieve and extract relevant information for annotation, all of which make use of BioOntologies.
GoPubMed
GoPubMed 13 is an ontology-based literature search tool, which extracts GO terms from PubMed abstracts retrieved by keyword search. PubMed is a service of the U.S. are then used to induce a relevant and browsable sub-ontology, which allows for a quick navigation from general to more specific terms, due to the hierarchical nature of GO.
GoPubMed makes use of the Gene Ontology for two different tasks: GO term extraction, which uses an algorithm that explores the inherent characteristics of GO (hierarchy and substring relationships between terms), and the construction of the minimal sub-ontology that contains all the extracted terms. These allow enhanced keyword searches, which usually demand a good understanding of the domain to obtain good results. The technique allows detection of relevant keywords derived from GO, even when they are not mentioned in the articles.
The tool also enables exploration of the abstracts at different levels of detail by structuring them according to the induced sub-ontology, making the large amounts of information retrieved more manageable (Delfs et al, 2004) .
GoPubMed refines traditional PubMed keyword search by incorporating domain knowledge from GO, gearing it towards the molecular biology community. It provides researchers with a more relevant and structured set of results, which could be overlooked when using PubMed queries.
Textpresso
Textpresso 14 is an ontology-based information retrieval and extraction system for biomedical literature first developed for C. elegans. Instead of using an established ontology, like GO, Textpresso uses its own ontology, which is organized into a shallow hierarchy with several parent categories of terms, some of which overlap GO and constitute the majority of the Textpresso lexicon. These categories are split into three groups: the first consists of biological entities, such as genes, cells or species;
the second group contains terms that characterize a biological entity or establish a relation between two of them (e.g. binding, regulation); the third group contains auxiliary categories involved in semantic analyses of sentences.
Textpresso contains a collection of full-text scientific articles where each word or phrase is labelled according to the Textpresso lexicon, which makes it is easier to query.
The search engine of Textpresso allows the user to formulate queries by combining keywords and Textpresso categories, which enables the formulation of semantic queries that impart much more meaning than simple keyword searches. The user can query against whole categories to retrieve all the information pertaining to a broad area, or he can combine keywords, categories and sub-categories to confine the search to a more specific theme. The categories that include entities and relationships enable the semantic contextualization of the query, whereas the auxiliary categories allow for a better retrieval of the relevant information from the texts. So the user queries the literature in the framework of the ontology and obtains sentences to be inspected. A typical result page shows a list of documents with all bibliographical information, abstract and all sentences having a match for an ontology term, links for the full-text available online; PubMed related articles are also provided when available (Müller et al, 2004) . GOAnnotator then extracts GO terms from the documents and ranks them according to their similarity to the GO terms present in the uncurated annotations (see Figures 4 and 5).
GOAnnotator uses the Gene Ontology for two tasks: recognize terms in the text and, as a framework for calculating the semantic similarity between pairs of terms.
The extraction of GO terms is performed by FiGO, a rule-based method that does not use make use of NLP techniques and does not require manual intervention. FiGO assigns a confidence value to each GO term that represents the terms' likelihood of being mentioned in the text based on the nomenclature of GO.
GOAnnottor uses the Gene Ontology Annotation (GOA) database, which provides GO annotations to proteins in the UniProt Knowledgebase (UniProtKB) and
International Protein Index (IPI). GOA is a central dataset for other major multispecies databases, such as Ensembl and NCBI. GOAnnotator ranks the documents based on the extracted GO terms from the text and their similarity to the GO terms present in the uncurated annotations, using the measure proposed by Lin (Lin, 1998) .
This measure combines GO hierarchy and term usage in the GOA database to achieve a measure of GO term semantic similarity . . GOAnnotator: For each uncurated annotation, GOAnnotator shows the similar GO terms extracted from a sentence of the selected document. If any of the sentences provides correct evidence for the uncurated annotation, or if the evidence supports a GO term similar to that present in the uncurated annotation, the curator can use the Add option to store the annotation together with the document reference, the evidence codes and any comments.
The use of BioOntologies
The tools reviewed above make use of BioOntologies in quite diverse manners (see Table 1 ). The most straightforward approach is implemented by EBIMed, where
BioOntologies are used as a source of terminology to match the entities present in the literature. BioOntologies also provide evidence of association between different kinds of bioentities. Textpresso, on the other hand, uses its own built-in BioOntology to allow word meaning to be queried. The possibility of semantic query formulation enables the usage of this tool both as a search engine and as a curation tool.
GoPubMed uses both the concepts and the structure of its BioOntology, not only matching the concepts to terms in the literature, but also exploring the hierarchical relationships among the retrieved terms to provide a multi-level navigation interface for accessing the retrieved texts at different resolutions. GOAnnotator goes beyond concept definition and ontology structure, by integrating both to calculate similarities between concepts. This enables this tool propose new annotations in addition to retrieving evidences from text support existing annotations. 
GOAnnotator

FUTURE PROSPECTS
Due to the quantity and diversity of information it generates, the biomedical sciences are one of the most promising fields for application of ontologies and text mining. The growth of both domains has been mostly the result of investments from large research consortia, which conduct expensive projects that have generated and maintain most of the publicly available biomedical data. Nevertheless, small institutions with limited resources play an important role, complementing the available data and developing innovative approaches that could grow into important trends. For instance, the management of well-founded and broad BioOntologies is clearly an issue to be addressed by large research institutes, but smaller institutions are making important contributions on the development of useful tools to explore that information.
Because of the diversity and evolving nature of biomedical information, designing BioOntologies is a complex task. It requires agreement among the members of a community to define the concepts within its scope, and constant involvement from that community to correct and complete those definitions, since the concepts can change with time or become obsolete, and new concepts can arise. As the success of a BioOntology is directly related to involvement of the community, ontology developers should always consider their expectations and limitations, both when designing and updating a BioOntology.
While BioOntologies are traditionally used mainly for annotation purposes, their ultimate goal should be to accurately represent the domain knowledge so as to allow automated reasoning and support knowledge extraction. The establishment of guiding principles, as in OBO, to guide the development of new BioOntologies is a step in this direction, by promoting formality, enforcing orthogonality, and proposing a common syntax that facilitates mapping between BioOntologies. This not only improves the quality of individual BioOntologies, but also enables the concerted use of several BioOntologies by computational methods.
However, from the point of view of TM applications, current BioOntologies are still too incomplete, too inconsistent and/or too morpho-syntactically inflexible to efficiently support them. To overcome these limitations, BioOntologies could be designed with TM in mind, for instance by taking advantage of more complex NLP techniques rather than simple text statistics, or even by applying TM techniques in their construction to expand their coverage through automated population and improve their interoperability through automated mapping and integration.
While Bioinformatics has been essential to deal with the growing amount of data and knowledge in Biomedical sciences, its whole potential is still unrealised and it will doubtlessly play a major role in their ultimate goal: understanding how living systems function, and understanding life as a whole (Ideker et al., 2001) . Many relevant biological discoveries in the future will result from an efficient exploitation of the existing and newly generated data, which will require innovative and efficient data management and integration approaches. Prominent among these will certainly be the development and use of BioOntologies.
AKNOWLEDGMENTS
This work was partially supported by the Portuguese 'Fundação para a Ciência e 
